MRgFUS is an incision-free treatment method guided by magnetic resonance imaging, used in the treatment of movement disorders. The foundation of the treatment involves directing focused ultrasound waves in a controlled manner toward the target brain regions responsible for the disease, primarily the focus of tremors.

Before treatment, the patient undergoes a specific preparation process. To ensure precise targeting, the head is stabilized, and a stereotactic frame is placed. During this stage, local anesthesia is applied. At the same time, a specialized cooling system is used on the head area to balance the heat increase that may occur during the procedure.

Once preparation is complete, the patient is placed into the magnetic resonance scanner with the frame attached. The patient remains awake and communicative with the physicians throughout the entire treatment. Using high-resolution MR images, the brain regions responsible for the disease, particularly tremors, are identified with millimetric precision.

During the application, ultrasound waves are initially sent to the target area at low energy. At this stage, temperature changes are monitored via MRI, and the clinical effect is evaluated. Once the accuracy of the target and the response are confirmed, controlled energy is applied to create a permanent effect.

The entire process progresses through simultaneous imaging and clinical evaluation. In this way, both targeting accuracy and safety are prioritized. The procedure generally takes a few hours, and patients are often discharged on the same day.

MRgFUS is a treatment method that requires meticulous planning and patient selection. When evaluated for suitable patients, it can offer a significant option for reducing the impact of tremors on daily life or alleviating the primary symptoms of Parkinson's Disease. The treatment decision must always be made through detailed neurological evaluation and personalized planning.

‍